Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(9):e45724.
doi: 10.1371/journal.pone.0045724. Epub 2012 Sep 25.

The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study

Affiliations

The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study

Florian M Marx et al. PLoS One. 2012.

Erratum in

  • PLoS One. 2013;8(8). doi: 10.1371/annotation/ea5f2a13-4394-41af-84c8-3e6af4a07770

Abstract

Rationale: High rates of recurrent tuberculosis after successful treatment have been reported from different high burden settings in Sub-Saharan Africa. However, little is known about the rate of smear-positive tuberculosis after treatment default. In particular, it is not known whether or not treatment defaulters continue to be or become again smear-positive and thus pose a potential for transmission of infection to others.

Objective: To investigate, in a high tuberculosis burden setting, the rate of re-treatment for smear-positive tuberculosis among cases defaulting from standardized treatment compared to successfully treated cases.

Methods: Retrospective cohort study among smear-positive tuberculosis cases treated between 1996 and 2008 in two urban communities in Cape Town, South Africa. Episodes of re-treatment for smear-positive tuberculosis were ascertained via probabilistic record linkage. Survival analysis and Poisson regression were used to compare the rate of smear-positive tuberculosis after treatment default to that after successful treatment.

Results: A total of 2,136 smear-positive tuberculosis cases were included in the study. After treatment default, the rate of re-treatment for smear-positive tuberculosis was 6.86 (95% confidence interval [CI]: 5.59-8.41) per 100 person-years compared to 2.09 (95% CI: 1.81-2.41) after cure (adjusted Hazard Ratio [aHR]: 3.97; 95% CI: 3.00-5.26). Among defaulters, the rate was inversely associated with treatment duration and sputum conversion prior to defaulting. Smear grade at start of the index treatment episode (Smear3+: aHR 1.61; 95%CI 1.11-2.33) was independently associated with smear-positive tuberculosis re-treatment, regardless of treatment outcome.

Conclusions: In this high-burden setting, there is a high rate of subsequent smear-positive tuberculosis after treatment default. Treatment defaulters are therefore likely to contribute to the pool of infectious source cases in the community. Our findings underscore the importance of preventing treatment default, as a means of successful tuberculosis control in high-burden settings.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Overview of smear-positive tuberculosis cases included in and excluded from the study.
Figure 2
Figure 2. Ascertainment of subsequent episodes of re-treatment via record linkage and manual review for the study.
Figure 3
Figure 3. Kaplan Meier failure estimates of re-treatment for smear-positive tuberculosis by index episode sputum smear grading and treatment outcome.
Figure 4
Figure 4. Kaplan Meier failure estimates of smear-positive re-treatment after treatment default, stratified by smear conversion prior to defaulting (adjusted for time to default).

References

    1. Santha T (2004) What is the optimum duration of treatment? In: Toman’s Tuberculosis: Case Detection, Treatment, and Monitoring (p144); Geneva: World Health Organization, 2004. (ISBN: 9241546034).
    1. [No authors listed] (1981) Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months. Tubercle 62: 95–102. - PubMed
    1. [No authors listed] (1986) Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis 133: 779–783. - PubMed
    1. [No authors listed] (1986) A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore. Am Rev Respir Dis 134: 27–33. - PubMed
    1. Dye C, Garnett GP, Sleeman K, Williams BG (1998) Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 352: 1886–1891. - PubMed

Publication types

Substances